Chronic Liver Failure in Decompensated Cirrhosis with Hepatic Hydrothorax

This protocol addresses patients with chronic liver failure in the setting of decompensated cirrhosis who develop pleural fluid accumulation (hepatic hydrothorax), confirmed as a transudate, where cardiac, pulmonary, and primary pleural causes have been excluded.

Clinical Scenario

Hepatic hydrothorax describes the accumulation of transudate in the pleural space of patients with decompensated liver cirrhosis in the absence of cardiac, pulmonary, or pleural disease. This presentation requires specific management distinct from other causes of pleural effusion.

Treatment Approach

First-line management combines a medical component targeting fluid retention with a procedural intervention directed at the pleural accumulation itself. Symptomatic patients — particularly those with dyspnoea — have a specific indication for timely pleural drainage. The complete structured regimen, including sequencing and criteria for each step, is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

Hepatic hydrotorax describes the accumulation of transudate in the pleural space of patients with decompensated cirrhosis in the absence of cardiac, pulmonary or pleural disease.
Diuretics and thoracentesis are recommended as the first-line management of hepatic hydrothorax (III;1).
Therapeutic thoracentesis is indicated in patients with dyspnoea (III;1).

DOI: 10.1016/j.jhep.2018.03.024

View source ↗